Evolent Health, Inc.(EVH)Earnings, Financials & Key RatiosEvolent Health, Inc. (EVH) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
which suggests significant long-term solvency risks.
Evolent Health, Inc. (EVH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Evolent Health, Inc. (EVH) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.02vs $0.05+60.0% | $496Mvs $534M-7.1% |
| Q1 2026 | Feb 24, 2026 | $0.08vs $0.06+33.3% | $469Mvs $469M+0.0% |
| Q4 2025 | Nov 6, 2025 | $0.05vs $0.10-50.0% | $480Mvs $468M+2.4% |
| Q3 2025 | Aug 7, 2025 | $0.10vs $0.09-211.1% | $444Mvs $532M-16.5% |
Recent stock market news and headlines for Evolent Health, Inc. (EVH)
Evolent Health, Inc (EVH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EVH's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Key metrics vs top competitors for Evolent Health, Inc. (EVH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $5.48 | $616.4M | -1.08 | -26.56% | -28.49% | -75.47% | 1.78% | |
| $28.26 | $2.34B | 128.45 | -10.86% | -2.42% | -1.59% | — | |
| $24.05 | $4.91B | -6500.00 | 46.06% | 0.47% | 11.5% | — | |
| $96.98 | $8.11B | 39.42 | 9.47% | 17.25% | 10.94% | — | |
| $9.10 | $1.64B | -7.98 | -1.54% | -6.81% | -12.37% | — | |
| $31.12 | $8.07B | -18.41 | 27.5% | -0.3% | -3.26% | — |
Evolent Health, Inc. (EVH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Evolent Health, Inc. (EVH) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
Feb 24, 2026·SEC
Dec 8, 2025·SEC
Get notified when EVH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Evolent Health, Inc. (EVH) stock FAQ — growth, dividends, profitability & financials explained
Evolent Health, Inc. (EVH) reported $1.89B in revenue for fiscal year 2025. This represents a 22532% increase from $8.3M in 2012.
Evolent Health, Inc. (EVH) saw revenue decline by 26.6% over the past year.
Evolent Health, Inc. (EVH) reported a net loss of $496.5M for fiscal year 2025.
Yes, Evolent Health, Inc. (EVH) pays a dividend with a yield of 1.78%. This makes it attractive for income-focused investors.
Evolent Health, Inc. (EVH) has a return on equity (ROE) of -75.5%. Negative ROE indicates the company is unprofitable.
Evolent Health, Inc. (EVH) generated $1.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
